Central India Chronicle

Anatomic Pathology Market to Worth $49.1 Billion by 2026 | Industry to Rise at CAGR 7.0%: MarketsandMarkets Analysis

 Breaking News
  • No posts were found

Anatomic Pathology Market to Worth $49.1 Billion by 2026 | Industry to Rise at CAGR 7.0%: MarketsandMarkets Analysis

March 15
10:36 2023
Anatomic Pathology Market to Worth $49.1 Billion by 2026 | Industry to Rise at CAGR 7.0%: MarketsandMarkets Analysis
F. Hoffmann-La Roche AG (Switzerland) was the leading player in the anatomic pathology market. The company has a wide range of products in the consumables segment. Strong business operations across all key regions, coupled with a strong brand image, make the firm a leading player in this market.
The Anatomic Pathology Market players are focused on adopting strategies such as collaborations, acquisitions, and product launches to gain a competitive edge in the market

The global Anatomic Pathology Market in terms of revenue was estimated to be worth $35.1 billion in 2021 and is poised to reach $49.1 billion by 2026, growing at a CAGR of 7.0% from 2021 to 2026. Growing demand for personalized medicines and increasing number of cancer and infectious disease cases are the key drivers of the market, according to a report by MarketsandMarkets.

Anatomic pathology is a medical specialty that deals with the diagnosis, classification, and interpretation of diseases and abnormalities through the examination of tissues, organs, and bodily fluid. It is a crucial part of the diagnosis and treatment of various diseases, including cancer. The medical field is rapidly advancing with the development of advanced technology, such as digital pathology and image analysis. This, in turn, is expected to boost the anatomic pathology market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

Moreover, the increasing adoption of personalized medicines and other treatments, such as gene therapy, is fueling the growth of the market. The increase in the number of cancer cases has also propelled the demand for anatomic pathology tests, thereby contributing to the market growth.

Furthermore, the increasing demand for tissue-based diagnosis, especially in the diagnosis and treatment of cancer, is also expected to drive the market. This is due to the accuracy and reliability of these tests, which allow for early and accurate diagnosis. Moreover, the increasing awareness about the importance of anatomic pathology tests, especially in the diagnosis of cancer and other diseases, is expected to propel the market.

The market is segmented on the basis of product & services, application, end user, and geography. By product & services, the market is divided into reagents & kits, instruments, and software & services. Among these, the reagents & kits segment is expected to hold the largest share of the market during the forecast period. This is due to the increasing availability of different types of reagents, such as antibodies and stains, used in anatomic pathology.

The increasing demand for anatomic pathology tests in the diagnosis and treatment of cancer is expected to drive the segment. Furthermore, the rising demand for instruments, such as automated slide staining and tissue microarray systems, is also expected to boost the segment.

The increasing awareness about the importance of anatomic pathology tests, especially in the diagnosis and treatment of cancer, is expected to propel the market. Furthermore, the availability of advanced technology, such as digital pathology and image analysis, is expected to boost the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145

Key Market Players

The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).

This research report categorizes the anatomic pathology market into the following segments and subsegments:

By Product and Service

  • Services
  • Consumables
  • Instruments

By Application

  • Disease Diagnostics
  • Medical Research

By End User

  • Hospital Laboratories
  • Clinical Laboratories
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Recent Developments:

  • Hologic received premarket approval (PMA) from the FDA for its ThinPrep GenesisTM processor for cytology processing and specimen transfer for downstream applications.
  •  PHC Holding Corporation completed the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business to strengthen its position in the diagnostics segment.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=137323145

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html

Related Articles